Badgley Phelps Wealth Managers’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
Badgley Phelps Wealth Managers's NVO Position: Q2 2026 in Review
Badgley Phelps Wealth Managers opened a new position in Novo Nordisk (NVO) in Q2 2026: 4,861 shares worth $233K. The stake represents ﹤0.01% of the portfolio and ranks #314 among its holdings. This is a return to the name: Badgley Phelps Wealth Managers previously reported a position in NVO as recently as Q3 2025.
Badgley Phelps Wealth Managers first reported a position in NVO in Q4 2021 and has held it in 17 quarters since. The position peaked at $640K in Q3 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Badgley Phelps Wealth Managers held 4,861 shares of Novo Nordisk worth $233K as of Q2 2026.
- Novo Nordisk was a new Badgley Phelps Wealth Managers position in Q2 2026.
- Novo Nordisk made up ﹤0.01% of Badgley Phelps Wealth Managers's portfolio in Q2 2026, its #314 holding.
- Badgley Phelps Wealth Managers first reported a position in Novo Nordisk in Q4 2021 and has held it in 17 quarters since.
- Badgley Phelps Wealth Managers's Novo Nordisk position peaked at $640K in Q3 2024.
- 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Badgley Phelps Wealth Managers's 13F filing for Q2 2026, filed 31 Jul 2026.